Autopsy report · NCT05276401

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

“Request for additional preclinical data.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 1 year 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Lakewood-Amedex Inc

Sponsor type

Industry

Conditions

Chronic Diabetic Foot Ulcers

Interventions

5% Bisphosphocin Topical Gel; Placebo Topical Gel; 10% Bisphosphocin Topical Gel

Participants

3

Sites

5

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.